Clean ClAImsFirst Pass

Maverick AI

Real-time autonomous medical coding for revenue cycle teams

Our take

Maverick AI, founded in 2019 by Yossi Shahak and Michael Brozino with teams in Israel and the US, builds mCoder, an autonomous medical coding platform. mCoder reads clinical documentation and assigns codes in real time, streaming results to the billing system in seconds. The company reports an 85%+ direct-to-bill rate, meaning roughly nine in ten cases are coded without human intervention, with 95% coding accuracy. Buyers are coding and revenue cycle leaders at high-volume outpatient organizations such as radiology groups and urgent care networks, plus RCM companies coding on providers' behalf.

Its flagship deployment is RadNet, the largest US outpatient imaging network, which completed an mCoder implementation across its imaging sites in late 2024. In August 2025 Infinx, an AI patient access and revenue cycle vendor, made a strategic investment in Maverick and is embedding its real-time coding in the Infinx platform. Disclosed funding is modest, about $11.5M per PitchBook including a $5M 2022 seed; reports of a $47M round in this category refer to competitor Nym. Maverick competes with Nym, CodaMetrix, and Fathom on coding automation rates and specialty coverage.

What it does

  • Real-time autonomous coding via the mCoder platform
  • 85%+ direct-to-bill rate without human touch
  • Codes most cases in seconds
  • Reported 95% coding accuracy
  • Streams coded results straight to billing systems

Where it's strong

  • Real-time coding with a published 85%+ direct-to-bill rate, ahead of the batch processing common in the category.
  • Proven at national scale through the RadNet implementation across US imaging sites.
  • The Infinx investment and partnership give it a distribution channel into established RCM operations.

What buyers should weigh

  • Widely cited reports of a $47M 2025 raise belong to competitor Nym, not Maverick; Maverick's disclosed funding is about $11.5M, so weigh vendor financial durability.
  • Public proof points are concentrated in radiology; ask for evidence in other specialties.
  • Roughly 15% of cases still route to human coders, so plan for a review workflow.

Latest

Infinx made a strategic investment in Maverick AI in August 2025 to bring real-time autonomous coding to its revenue cycle platform.

Also in Autonomous Medical Coding

Track this market

First Pass covers Autonomous Medical Coding and the rest of the getting-paid stack every week.